MEDIFIRST SOLUTIONS, INC. ANNOUNCES UPDATE TO SHAREHOLDERS
24 February 2016 - 1:45AM
InvestorsHub NewsWire
Freehold, NJ -- February 23, 2016 -- InvestorsHub NewsWire
-- MEDIFIRST SOLUTIONS, INC. (OTCQB:
MFST) (the “company” or “Medifirst”) would like to follow up
and update its shareholders on the progress of its 510(k)
submission including the request for more information from the Food
and Drug Administration (FDA). As part of the review process, when
more information is requested, the FDA allows the company 180 days
to respond. Commented CEO Bruce J. Schoengood, “We are pleased to
announce that we anticipate completion of the response to the FDA’s
request for more information by the end of March.” To facilitate
the response, Medifirst has engaged an industry leading laboratory
and testing facility that employs over 38,000 people in 1,000
locations in over 100 countries. They hold extensive global
accreditations, recognitions, and agreements and their knowledge
and expertise is in overcoming regulatory, market, and supply chain
hurdles. Medifirst has engaged this company to perform a test known
as the IEC 60601-1-2 Medical Electrical Equipment Part 1-2: General
Requirements for Safety: Electromagnetic Compatibility.
Continued CEO Schoengood, “Additional testing has already been
completed and other requests will be completed in the upcoming days
and weeks, including technical and informational revisions and
updates to the product’s manuals and labels. We are very pleased to
be working with one of the biggest labs in the industry and we are
excited to be aggressively responding to the FDA request for more
information. We appreciate the support and patience of our
shareholders and the company will continue to update its
shareholders on a regular basis.” Medifirst believes that its laser
devices are very unique and offer an easy-to-use, mobile,
affordable and effective product for many different health care
professionals. The Time Machine Laser System can serve to enhance
the current treatment protocols of various health care
professionals, as well as produce additional revenue streams from
the treatment range Medifirst believes The Time Machine Infrared
Laser System is capable of delivering. Please visit
www.medifirstsolutions.com and the Medifirst social media pages for
more information.
Contact: Investor Relations
Phone: (732) 786-8044
Email:
info@medifirstsolutions.com
Website: www.medifirstsolutions.com
About the Lasers
Medical Lasers Manufacturer, Inc. (“MLM”), a Medifirst subsidiary,
will specialize in producing high quality diode-pumped solid-state
lasers. The laser division, including products and treatment
programs, will be operated out of MLM. The company’s focus is to
help patients with specific cosmetic skin conditions, as well as
relief of muscle and joint pain and muscle spasm and inflammation.
MLM’s manufacturer consists of a group of engineers with decades of
experience in laser research and manufacturing that have been
providing customized laser products to a wide variety of
universities and labs.Driven by the huge demand for minimally
invasive skin and pain treatments, the global market for medical
and therapeutic lasers have been estimated to grow as high as to $4
billion in 2015.
About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is
headquartered in New Jersey. The company seeks innovative medical
and healthcare products and technologies which are targeted to both
medical and healthcare professionals, as well as everyday
consumers. Medifirst is developing and establishing both consumer
and professional medical cliental that can serve as a pipeline that
will allow for distribution of future products and services. For
more details visit www.medifirstsolutions.com for more
information.
# # #
Forward-Looking Statements: The statements in this press
release that relate to the company's expectations with regard to
the future impact on the company's results from new products in
development are forward-looking statements, and may involve risks
and uncertainties, some of which are beyond our control. Such
risks and uncertainties are described in greater detail in our
filings with the U.S. Securities and Exchange Commission.
Since the information in this press release may contain statements
that involve risk and uncertainties and are subject to change at
any time, the company's actual results may differ materially from
expected results. We make no commitment to disclose any
subsequent revisions to forward-looking statements.